Human exhaled air analytics: biomarkers of diseasesBuszewski, Bogusław; Kęsy, Martyna; Ligor, Tomasz; Amann, Anton
doi: 10.1002/bmc.835pmid: 17431933
Over the last few years, breath analysis for the routine monitoring of metabolic disorders has attracted a considerable amount of scientific interest, especially since breath sampling is a non‐invasive technique, totally painless and agreeable to patients. The investigation of human breath samples with various analytical methods has shown a correlation between the concentration patterns of volatile organic compounds (VOCs) and the occurrence of certain diseases. It has been demonstrated that modern analytical instruments allow the determination of many compounds found in human breath both in normal and anomalous concentrations. The composition of exhaled breath in patients with, for example, lung cancer, inflammatory lung disease, hepatic or renal dysfunction and diabetes contains valuable information. Furthermore, the detection and quantification of oxidative stress, and its monitoring during surgery based on composition of exhaled breath, have made considerable progress. This paper gives an overview of the analytical techniques used for sample collection, preconcentration and analysis of human breath composition. The diagnostic potential of different disease‐marking substances in human breath for a selection of diseases and the clinical applications of breath analysis are discussed. Copyright © 2007 John Wiley & Sons, Ltd.
Quantitative liquid chromatography/time‐of‐flight mass spectrometryWilliamson, Leah N.; Bartlett, Michael G.
doi: 10.1002/bmc.844pmid: 17474074
Over the last decade, time‐of‐flight (TOF) instruments have increasingly been used as quantitation tools. In addition, because of their high resolving power, they can be used for verification of empirical formulas. Historically, TOF instruments have had limited quantitation capabilities because of their narrow dynamic range. However, recent advances have improved these limitations. This review covers the rationale for using TOF for LC detection, and describes the many methods currently in the literature for the quantitation of pharmaceuticals, environmental pollutants, explosives and many phytochemicals. Copyright © 2007 John Wiley & Sons, Ltd.
HPLC determination of safflor yellow A and three active isoflavones from TCM Naodesheng in rat plasma and tissues and its application to pharmacokinetic studiesYu, Zhiguo; Gao, Xiaoxia; Zhao, Yunli; Bi, Kaishun
doi: 10.1002/bmc.764pmid: 17385809
A high‐performance liquid chromatographic method was developed for the simultaneous determination and pharmacokinetic studies of safflor yellow A, puerarin, 3′‐methoxyl‐puerarin, and puerarinapioside in the plasma and tissues of rats that had been administered with the traditional Chinese medicine (TCM) preparation Naodesheng via the caudal vein. Samples taken from rats were subjected to protein precipitation with acetone. Separation of these four compounds was accomplished on a Kromisil C18 stationary phase using a mobile phase of acetonitrile–0.1% phosphoric acid–tetrahydrofuran (8:92:2, v/v/v) at a flow‐rate of 1.0 mL/min. The detection wavelength was set at 250 nm. The calibration curves of the four components were linear in the given concentration ranges. The intra‐ and inter‐day precisions in plasma and tissues were less than 15% and the extraction recoveries were higher than 60%. The lower limits of quantitation of four components were low enough to determine the four components. These four components all exhibited kinetics that fitted a two‐compartment model in rats. The elimination half‐life was 1.19 h for safflor yellow A, 2.69 h for puerarin, 2.94 h for 3′‐methoxyl‐puerarin, and 0.87 h for puerarinapioside, respectively. Following administration of a single injection of Naodesheng, the concentration (C) of the four components in the tissues showed Ckidney > Clung, Cliver > Cspleen, Cstomach, Cheart, approximately. The method is a reliable tool for performing studies of safflor yellow A and three puerarin isoflavones in different biological material. Copyright © 2007 John Wiley & Sons, Ltd.
Quantification of dexamethasone and corticosterone in rat biofluids and fetal tissue using highly sensitive analytical methods: assay validation and application to a pharmacokinetic studySamtani, Mahesh N.; Jusko, William J.
doi: 10.1002/bmc.788pmid: 17385808
A sensitive, specific, accurate and precise LC/MS/MS method was developed for the simultaneous measurement of dexamethasone and corticosterone in rat plasma. The method was extended to dexamethasone analysis in rat plasma ultrafiltrate and fetal tissues. Samples were processed using SPE involving Oasis HLB cartridges, which offered complete extraction recovery for the analytes. Samples were subsequently analyzed using LC/MS/MS. A structurally related corticosteroid, prednisolone, was used as the internal standard. Using a 500 µL plasma sample, limits of quantification of 0.2 and 2.0 ng/mL were achievable for dexamethasone and corticosterone. This level of sensitivity allowed characterization of maternal/fetal dexamethasone profiles after administration of multiple doses of dexamethasone sodium phosphate to rats. However, this sensitivity was not satisfactory for corticosterone during pharmacokinetic studies involving dexamethasone due to its strong adrenosuppressive effect. This led us to investigate the suitability of a commercially available radioimmunoassay kit, which through extensive testing and minor modifications was found to offer extremely sensitive, specific, accurate and precise analysis of corticosterone. Knowledge of the steroid profiles captured using these highly sensitive analytical tools may potentially help in the optimization of corticosteroid therapy during pregnancy. Copyright © 2007 John Wiley & Sons, Ltd.
Pharmacokinetic study of salvianolic acid A in rat after intravenous administration of Danshen injectionHou, Yuan‐Yuan; Peng, Jia‐Min; Chao, Ruo‐Bing
doi: 10.1002/bmc.791pmid: 17326051
In order to research the pharmacokinetics of salvianolic acid A (SalA), a herbal ingredient isolated from Salvia miltiorrhiza Bunge, after intravenous administration to rats, a specific and accurate high‐performance liquid chromatography (HPLC) was developed. The assay procedure involved simple liquid–liquid extraction of SalA and internal standard (IS, ethyl‐p‐hydroxybenzoate) from plasma into ethyl acetate. The organic layer was separated and evaporated under reduced pressure at 40°C. The residue was reconstituted in the mobile phase and analyzed on an Inertsil C8 column, monitored at 285 nm. The mobile phase, which consisted of methanol–acetonitrile–water–formic acid (10:20:70:0.4, by vol), was used at a flow rate of 1.0 mL/min. The ratio of the peak area of the analyte to IS was applied to quantify the plasma samples. The standard curve for SalA was linear (r2 = 0.9999) in the concentration range of 0.75–150 µg/mL. The limit of quantitation (LOQ) of SalA was 0.75 µg/mL. The intra‐ and inter‐day precisions (RSD) of the quality control (QC) samples were in the ranges of 2.17–3.29 and 1.24–5.28%, respectively. Accuracy in the measurement of QC samples ranged from 94.7 to 101.1%. This method was validated for specificity, accuracy and precision and was successfully applied to the pharmacokinetic study of SalA in rat plasma after intravenous administration of Danshen injection. Copyright © 2007 John Wiley & Sons, Ltd.
Interaction study of aspirin or clopidogrel on pharmacokinetics of donepezil hydrochloride in rats by HPLC‐fluorescence detectionWada, Mitsuhiro; Nishiwaki, Junichiro; Yamane, Tomoko; Ohwaki, Yuichi; Aboul‐Enein, Hassan Y.; Nakashima, Kenichiro
doi: 10.1002/bmc.794pmid: 17340563
The present study aims to investigate the possibility of interaction of aspirin (Asp) or clopidogrel (CG) on donepezil (DP) hydrochloride in rats by HPLC‐fluorescence detection. The separation of DP was achieved in ca. 13 min without interference of Asp and CG on the chromatogram. DP levels in rat plasma with a single administration of DP (5 mg/kg, i.p., group I) and those with a co‐administration of Asp (200 mg/kg, p.o., group II or 200 mg/kg, i.p., group III) or CG (5 mg/kg, p.o., group IV) were monitored. The DP concentrations determined in rat plasma ranged from 25.0 to 336.1 ng/mL. Pharmacokinetic parameters for these groups were calculated and compared with one another. No significant difference was observed on the comparison of group I with other groups except for the mean resident time of group IV (p = 0.012). These basic findings may help clinical inference when DP is co‐administered with Asp and CG to human. Copyright © 2007 John Wiley & Sons, Ltd.
Liquid chromatography–tandem mass spectrometric assay for the nucleoside reverse transcriptase inhibitor emtricitabine in human plasmaSparidans, Rolf W.; Prins, Jan M.; Schellens, Jan H.M.; Beijnen, Jos H.
doi: 10.1002/bmc.797pmid: 17340566
A liquid chromatography–tandem mass spectrometric assay for the determination of the antiretroviral nucleoside emtricitabine in human plasma was developed and validated using a simple sample pre‐treatment procedure. After addition of 5′‐deoxy‐5‐fluorocytidine as the internal standard and protein precipitation with acetonitrile, the supernatant was directly injected in the isocratic chromatographic system using a polar embedded reversed‐phase column and formic acid in water–methanol as the eluent. The eluate was completely led into an electrospray interface with positive ionization and the analytes were quantified using triple quadrupole mass spectrometry. The assay was validated in the range 5–5000 ng/mL. Intra‐day precisions were ≤7% and inter‐day precisions were ≤10%. Accuracies between 92 and 99% were found. The analytes were chemically stable under all relevant conditions and the assay was applied in the analysis of plasma samples of HIV‐infected patients treated with the drug. Copyright © 2007 John Wiley & Sons, Ltd.
Development of an ion‐pair HPLC method for investigation of energy charge changes in cerebral ischemia of mice and hypoxia of Neuro‐2a cell lineChen, Yunyun; Xing, Dongming; Wang, Wei; Ding, Yi; Du, Lijun
doi: 10.1002/bmc.798pmid: 17385810
The determination of adenine nucleotides and energy charge (EC) has great importance in the characterization of cerebral ischemic injury and post‐ischemic recovery. An IP‐HPLC method was developed for the quantification of AMP, ADP, ATP and EC in cerebral ischemia and hypoxia of the Neuro‐2a cell line. The chromatographic conditions were: a Zorbax SB‐C18 reversed‐phase column; mobile phase 100 mm KH2PO4, 1 mm tetrabutylammonium hydroxide, and 2.5% acetonitrile, brought to pH 7.0 with potassium hydroxide (4 m), filtered through a 0.45 µm Millipore filter and degassed prior to use. The flow‐rate was 1.0 mL/min. The injection volume was 20 µL. Detection was performed at a wavelength of 254 nm under a constant temperature (27 ± 1°C). The method was validated by means of linearity, using calibration curves constructed with five concentration levels of each compound. The limit of detection was also determined. The system precision was calculated as the coefficient of variation for five injections for each compound tested. Cerebral tissue was homogenized (4°C) in 1 mL of an ice‐cold 6% trichloroacetic acid that contained ATPase inhibitor and obtained good recovery (>90%). The results show that the described method for the determination of adenine nucleotides by HPLC has good linearity, limit of detection, precision and specificity, and is simple and rapid to perform. Copyright © 2007 John Wiley & Sons, Ltd.